{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:05:31Z","timestamp":1792785931515,"version":"4.5.0"},"reference-count":108,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T00:00:00Z","timestamp":1687478400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18\/01122"],"award-info":[{"award-number":["PI18\/01122"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI21\/00116"],"award-info":[{"award-number":["PI21\/00116"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Development Regional Fund"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>Current knowledge about the consequences of PCOS during the late reproductive years and after menopause is limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE AND RATIONALE<\/jats:title>\n                    <jats:p>We performed a systematic review and meta-analysis of data on the pathophysiology, clinical manifestations, diagnosis, prognosis, and treatment of women \u226545\u2009years of age\u2014peri- or postmenopausal\u2014with PCOS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SEARCH METHODS<\/jats:title>\n                    <jats:p>Studies published up to 15 April 2023, identified by Entrez-PubMed, EMBASE, and Scopus online facilities, were considered. We included cross-sectional or prospective studies that reported data from peri- or postmenopausal patients with PCOS and control women with a mean age \u226545\u2009years. Three independent researchers performed data extraction. Meta-analyses of quantitative data used random-effects models because of the heterogeneity derived from differences in study design and criteria used to define PCOS, among other confounding factors. Sensitivity analyses restricted the meta-analyses to population-based studies, to studies including only patients diagnosed using the most widely accepted definitions of PCOS, only menopausal women or only women not submitted to ovarian surgery, and studies in which patients and controls presented with similar indexes of weight excess. Quality of evidence was assessed using the GRADE system.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OUTCOMES<\/jats:title>\n                    <jats:p>The initial search identified 1400 articles, and another six were included from the reference lists of included articles; 476 duplicates were deleted. We excluded 868 articles for different reasons, leaving 37 valid studies for the qualitative synthesis, of which 28 studies\u2014published in 41 articles\u2014were considered for the quantitative synthesis and meta-analyses. Another nine studies were included only in the qualitative analyses. Compared with controls, peri- and postmenopausal patients with PCOS presented increased circulating total testosterone (standardized mean difference, SMD 0.78 (0.35, 1.22)), free androgen index (SMD 1.29 (0.89, 1.68)), and androstenedione (SMD 0.58 (0.23, 0.94)), whereas their sex hormone-binding globulin was reduced (SMD \u22120.60 (\u22120.76, \u22120.44)). Women with PCOS showed increased BMI (SMD 0.57 (0.32, 0.75)), waist circumference (SMD 0.64 (0.42, 0.86)), and waist-to-hip ratio (SMD 0.38 (0.14, 0.61)) together with increased homeostasis model assessment of insulin resistance (SMD 0.56 (0.27, 0.84)), fasting insulin (SMD 0.61 (0.38, 0.83)), fasting glucose (SMD 0.48 (0.29, 0.68)), and odds ratios (OR, 95% CI) for diabetes (OR 3.01 (1.91, 4.73)) compared to controls. Women with PCOS versus controls showed decreased HDL concentrations (SMD \u22120.32 (\u22120.46, \u22120.19)) and increased triglycerides (SMD 0.31 (0.16, 0.46)), even though total cholesterol and LDL concentrations, as well as the OR for dyslipidaemia, were similar to those of controls. The OR for having hypertension was increased in women with PCOS compared with controls (OR 1.79 (1.36, 2.36)). Albeit myocardial infarction (OR 2.51 (1.08, 5.81)) and stroke (OR 1.75 (1.03, 2.99)) were more prevalent in women with PCOS than controls, the ORs for cardiovascular disease as a whole, coronary artery disease as a whole, breast cancer and age at menopause, were similar in patients and controls. When restricting meta-analysis to studies in which women with PCOS and controls had a similar mean BMI, the only difference that retained statistical significance was a decrease in HDL-cholesterol concentration in the former and, in the two studies in which postmenopausal women with PCOS and controls had similar BMI, patients presented with increased serum androgen concentrations, suggesting that hyperandrogenism persists after menopause, regardless of obesity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>WIDER IMPLICATIONS<\/jats:title>\n                    <jats:p>Hyperandrogenism appeared to persist during the late-reproductive years and after menopause in women with PCOS. Most cardiometabolic comorbidities were driven by the frequent coexistence of weight excess and PCOS, highlighting the importance of targeting obesity in this population. However, the significant heterogeneity among included studies, and the overall low quality of the evidence gathered here, precludes reaching definite conclusions on the issue. Hence, guidelines derived from adequately powered prospective studies are definitely needed for appropriate management of these women.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/humupd\/dmad015","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T10:32:06Z","timestamp":1685529126000},"page":"741-772","source":"Crossref","is-referenced-by-count":78,"title":["PCOS during the menopausal transition and after menopause: a systematic review and meta-analysis"],"prefix":"10.1093","volume":"29","author":[{"given":"Mercedes","family":"Mill\u00e1n-de-Meer","sequence":"first","affiliation":[{"name":"Universidad de Alcal\u00e1 , Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6002-4237","authenticated-orcid":false,"given":"Manuel","family":"Luque-Ram\u00edrez","sequence":"additional","affiliation":[{"name":"Universidad de Alcal\u00e1 , Madrid, Spain"},{"name":"Department of Endocrinology and Nutrition, Hospital Universitario Ram\u00f3n y Cajal , Madrid, Spain"},{"name":"Grupo de Diabetes, Obesidad y Reproducci\u00f3n Humana, Universidad de Alcal\u00e1 & Instituto Ram\u00f3n y Cajal de Investigaci\u00f3n Sanitaria (IRYCIS) & Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Diabetes y Enfermedades Metab\u00f3licas Asociadas (CIBERDEM) , Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9758-9397","authenticated-orcid":false,"given":"L\u00eda","family":"Nattero-Ch\u00e1vez","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Nutrition, Hospital Universitario Ram\u00f3n y Cajal , Madrid, Spain"},{"name":"Grupo de Diabetes, Obesidad y Reproducci\u00f3n Humana, Universidad de Alcal\u00e1 & Instituto Ram\u00f3n y Cajal de Investigaci\u00f3n Sanitaria (IRYCIS) & Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Diabetes y Enfermedades Metab\u00f3licas Asociadas (CIBERDEM) , Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6890-1644","authenticated-orcid":false,"given":"H\u00e9ctor F","family":"Escobar-Morreale","sequence":"additional","affiliation":[{"name":"Universidad de Alcal\u00e1 , Madrid, Spain"},{"name":"Department of Endocrinology and Nutrition, Hospital Universitario Ram\u00f3n y Cajal , Madrid, Spain"},{"name":"Grupo de Diabetes, Obesidad y Reproducci\u00f3n Humana, Universidad de Alcal\u00e1 & Instituto Ram\u00f3n y Cajal de Investigaci\u00f3n Sanitaria (IRYCIS) & Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Diabetes y Enfermedades Metab\u00f3licas Asociadas (CIBERDEM) , Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,6,23]]},"reference":[{"key":"2023110708004567100_dmad015-B1","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1210\/jc.2012-1683","article-title":"Management of postmenopausal virilization","volume":"97","author":"Alpanes","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2023110708004567100_dmad015-B2","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1210\/jc.2009-0839","article-title":"Criteria for polycystic ovarian morphology in polycystic ovary syndrome as a function of age","volume":"94","author":"Alsamarai","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2023110708004567100_dmad015-B3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12958-020-00576-1","article-title":"Risk of hypertension in women with polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression","volume":"18","author":"Amiri","year":"2020","journal-title":"Reprod Biol Endocrinol"},{"key":"2023110708004567100_dmad015-B4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s12020-021-02801-2","article-title":"Risk of type 2 diabetes mellitus in polycystic ovary syndrome is associated with obesity: a meta-analysis of observational studies","volume":"74","author":"Anagnostis","year":"2021","journal-title":"Endocrine"},{"key":"2023110708004567100_dmad015-B5","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/(SICI)1097-0142(19970201)79:3<494::AID-CNCR10>3.0.CO;2-Z","article-title":"Association of Stein-Leventhal syndrome with the incidence of postmenopausal breast carcinoma in a large prospective study of women in Iowa","volume":"79","author":"Anderson","year":"1997","journal-title":"Cancer"},{"key":"2023110708004567100_dmad015-B6","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1097\/HJH.0b013e3283630362","article-title":"Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype","volume":"31","author":"Armeni","year":"2013","journal-title":"J Hypertens"},{"key":"2023110708004567100_dmad015-B7","first-page":"2434","article-title":"A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain","volume":"85","author":"Asuncion","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2023110708004567100_dmad015-B8","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2023110708004567100_dmad015-B9","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/humupd\/7.6.522","article-title":"Polycystic ovary syndrome and cancer","volume":"7","author":"Balen","year":"2001","journal-title":"Hum Reprod Update"},{"key":"2023110708004567100_dmad015-B10","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/humupd\/dmu012","article-title":"Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"20","author":"Barry","year":"2014","journal-title":"Hum Reprod Update"},{"key":"2023110708004567100_dmad015-B11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1365-2265.1996.676498.x","article-title":"Polycystic ovaries in pre and post-menopausal women","volume":"44","author":"Birdsall","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2023110708004567100_dmad015-B12","doi-asserted-by":"crossref","first-page":"640.e1","DOI":"10.1016\/j.amjmed.2012.12.015","article-title":"Premature aging of cardiovascular\/platelet function in polycystic ovarian syndrome","volume":"126","author":"Chan","year":"2013","journal-title":"Am J Med"},{"key":"2023110708004567100_dmad015-B13","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.4158\/EP.14.9.1084","article-title":"Risk of cardiovascular events in mothers of women with polycystic ovary syndrome","volume":"14","author":"Cheang","year":"2008","journal-title":"Endocr Pract"},{"key":"2023110708004567100_dmad015-B14","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/humrep\/15.4.785","article-title":"Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome","volume":"15","author":"Cibula","year":"2000","journal-title":"Hum Reprod"},{"key":"2023110708004567100_dmad015-B15","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0015-0282(16)56575-3","article-title":"Hemostatic and metabolic variables in women with polycystic ovary syndrome","volume":"61","author":"Dahlgren","year":"1994","journal-title":"Fertil Steril"},{"key":"2023110708004567100_dmad015-B16","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0015-0282(16)54892-4","article-title":"Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones","volume":"57","author":"Dahlgren","year":"1992","journal-title":"Fertil Steril"},{"key":"2023110708004567100_dmad015-B17","first-page":"4895","article-title":"The association between knee osteoarthritis and polycystic ovary syndrome in postmenopausal women: preliminary results","volume":"25","author":"Deniz","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2023110708004567100_dmad015-B18","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocr Rev"},{"key":"2023110708004567100_dmad015-B19","doi-asserted-by":"crossref","first-page":"e12608","DOI":"10.1097\/MD.0000000000012608","article-title":"Association between polycystic ovarian syndrome and endometrial, ovarian, and breast cancer: a population-based cohort study in Taiwan","volume":"97","author":"Ding","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"2023110708004567100_dmad015-B20","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.fertnstert.2022.03.014","article-title":"Heart health in polycystic ovary syndrome: time to act on the data","volume":"117","author":"Dokras","year":"2022","journal-title":"Fertil Steril"},{"key":"2023110708004567100_dmad015-B21","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.metabol.2016.01.006","article-title":"Metabolic profile in women with polycystic ovary syndrome across adult life","volume":"65","author":"Echiburu","year":"2016","journal-title":"Metabolism"},{"key":"2023110708004567100_dmad015-B22","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1210\/jc.2017-02426","article-title":"Causes, patterns, and severity of androgen excess in 1205 consecutively recruited women","volume":"103","author":"Elhassan","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2023110708004567100_dmad015-B23","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/humrep\/16.3.556","article-title":"Prevalence of diabetes mellitus, hypertension and cardiac complaints in a follow-up study of a Dutch PCOS population","volume":"16","author":"Elting","year":"2001","journal-title":"Hum Reprod"},{"key":"2023110708004567100_dmad015-B24","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.tem.2007.07.003","article-title":"Abdominal adiposity and the polycystic ovary syndrome","volume":"18","author":"Escobar-Morreale","year":"2007","journal-title":"Trends Endocrinol Metab"},{"key":"2023110708004567100_dmad015-B25","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1210\/jc.2007-2053","article-title":"A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs","volume":"93","author":"Escobar-Morreale","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2023110708004567100_dmad015-B26","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment","volume":"14","author":"Escobar-Morreale","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"2023110708004567100_dmad015-B27","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1007\/s40618-021-01594-5","article-title":"Effect of aging on clinical features and metabolic complications of women with polycystic ovary syndrome","volume":"44","author":"Falcetta","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"2023110708004567100_dmad015-B28","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ejogrb.2023.04.008","article-title":"No difference in morbidity between perimenopausal women with PCOS with and without previous wedge resection","volume":"285","author":"Forslund","year":"2023","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2023110708004567100_dmad015-B29","doi-asserted-by":"crossref","first-page":"52","DOI":"10.31083\/j.ceog4902052","article-title":"Health-related quality of life in perimenopausal women with PCOS","volume":"49","author":"Forslund","year":"2022","journal-title":"Clin Exp Obstet Gynecol"},{"key":"2023110708004567100_dmad015-B30","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/aogs.13489","article-title":"Higher menopausal age but no differences in parity in women with polycystic ovary syndrome compared with controls","volume":"98","author":"Forslund","year":"2019","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2023110708004567100_dmad015-B31","doi-asserted-by":"crossref","first-page":"hoz042","DOI":"10.1093\/hropen\/hoz042","article-title":"Type 2 diabetes mellitus in women with polycystic ovary syndrome during a 24-year period: importance of obesity and abdominal fat distribution","volume":"2020","author":"Forslund","year":"2020","journal-title":"Hum Reprod Open"},{"key":"2023110708004567100_dmad015-B32","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1210\/clinem\/dgaa840","article-title":"Reproductive hormones and anthropometry: a follow-up of PCOS and controls from perimenopause to older than 80 years","volume":"106","author":"Forslund","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2023110708004567100_dmad015-B33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejogrb.2022.02.020","article-title":"Morbidity and mortality in PCOS: a prospective follow-up up to a mean age above 80 years","volume":"271","author":"Forslund","year":"2022","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2023110708004567100_dmad015-B34","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1477-7827-10-96","article-title":"Polycystic ovary syndrome in Salvador, Brazil: a prevalence study in primary healthcare","volume":"10","author":"Gabrielli","year":"2012","journal-title":"Reprod Biol Endocrinol"},{"key":"2023110708004567100_dmad015-B35","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.maturitas.2015.04.013","article-title":"Proposed criteria for the identification of polycystic ovary syndrome following menopause: an ancillary study of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)","volume":"81","author":"Gabrielli","year":"2015","journal-title":"Maturitas"},{"key":"2023110708004567100_dmad015-B36","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/oxfordjournals.aje.a116156","article-title":"Polycystic ovaries and the risk of breast cancer","volume":"134","author":"Gammon","year":"1991","journal-title":"Am J Epidemiol"},{"key":"2023110708004567100_dmad015-B37","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3109\/09513590.2016.1149812","article-title":"Cerebral white matter lesions and silent cerebral infarcts in postmenopausal women with polycystic ovary syndrome","volume":"32","author":"Guoqing","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"2023110708004567100_dmad015-B38","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/cen.14558","article-title":"The impact of ageing and menopause in women with polycystic ovary syndrome","volume":"97","author":"Helvaci","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2023110708004567100_dmad015-B39","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/humupd\/dml058","article-title":"Why does ovarian surgery in PCOS help? Insight into the endocrine implications of ovarian surgery for ovulation induction in polycystic ovary syndrome","volume":"13","author":"Hendriks","year":"2007","journal-title":"Hum Reprod Update"},{"key":"2023110708004567100_dmad015-B40","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/eci.12080","article-title":"Influence of obesity on atherogenic dyslipidemia in women with polycystic ovary syndrome","volume":"43","author":"Hern\u00e1ndez-Mijares","year":"2013","journal-title":"Eur J Clin Invest"},{"key":"2023110708004567100_dmad015-B41","first-page":"399","article-title":"Women younger than 50 years with endometrial cancer","volume":"27","author":"Iatrakis","year":"2006","journal-title":"Eur J Gynaecol Oncol"},{"key":"2023110708004567100_dmad015-B42","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1210\/jc.2016-3863","article-title":"Psychological distress is more prevalent in fertile age and premenopausal women with PCOS symptoms: 15-year follow-up","volume":"102","author":"Karjula","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2023110708004567100_dmad015-B43","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1210\/clinem\/dgz256","article-title":"Population-based data at ages 31 and 46 show decreased HRQoL and life satisfaction in women with PCOS symptoms","volume":"105","author":"Karjula","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2023110708004567100_dmad015-B44","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1210\/jc.2017-01829","article-title":"Androgens, irregular menses, and risk of diabetes and coronary artery calcification in the Diabetes Prevention Program","volume":"103","author":"Kim","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2023110708004567100_dmad015-B45","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10552-016-0716-7","article-title":"Polycystic ovarian syndrome (PCOS), related symptoms\/sequelae, and breast cancer risk in a population-based case-control study","volume":"27","author":"Kim","year":"2016","journal-title":"Cancer Causes Control"},{"key":"2023110708004567100_dmad015-B46","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.fertnstert.2009.05.039","article-title":"Reduced serum ghrelin in a putative postmenopausal polycystic ovary syndrome phenotype","volume":"92","author":"Krentz","year":"2009","journal-title":"Fertil Steril"},{"key":"2023110708004567100_dmad015-B47","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/GME.0b013e31802cc7ab","article-title":"Searching for polycystic ovary syndrome in postmenopausal women: evidence of a dose-effect association with prevalent cardiovascular disease","volume":"14","author":"Krentz","year":"2007","journal-title":"Menopause"},{"key":"2023110708004567100_dmad015-B48","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.metabol.2012.02.001","article-title":"Adipocytokine profiles in a putative novel postmenopausal polycystic ovary syndrome (PCOS) phenotype parallel those in premenopausal PCOS: the Rancho Bernardo Study","volume":"61","author":"Krentz","year":"2012","journal-title":"Metabolism"},{"key":"2023110708004567100_dmad015-B49","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/aogs.14382","article-title":"Women with polycystic ovary syndrome are burdened with multimorbidity and medication use independent of body mass index at late fertile age: a population-based cohort study","volume":"101","author":"Kujanp\u00e4\u00e4","year":"2022","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2023110708004567100_dmad015-B50","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1210\/er.2003-0004","article-title":"Polycystic ovary syndrome and cardiovascular disease: a premature association?","volume":"24","author":"Legro","year":"2003","journal-title":"Endocr Rev"},{"key":"2023110708004567100_dmad015-B51","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1093\/humrep\/dew264","article-title":"Common diseases as determinants of menopausal age","volume":"31","author":"Li","year":"2016","journal-title":"Hum Reprod"},{"key":"2023110708004567100_dmad015-B52","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s42000-020-00211-z","article-title":"Insulin resistance, androgens, and lipids are gradually improved in an age-dependent manner in lean women with polycystic ovary syndrome: insights from a large Caucasian cohort","volume":"19","author":"Livadas","year":"2020","journal-title":"Hormones (Athens)"},{"key":"2023110708004567100_dmad015-B53","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1530\/EJE-15-0646","article-title":"Referral bias in female functional hyperandrogenism and polycystic ovary syndrome","volume":"173","author":"Luque-Ramirez","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"2023110708004567100_dmad015-B54","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1210\/jc.2007-0190","article-title":"Obesity is the major determinant of the abnormalities in blood pressure found in young women with the polycystic ovary syndrome","volume":"92","author":"Luque-Ramirez","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2023110708004567100_dmad015-B55","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/HYPERTENSIONAHA.113.02468","article-title":"Office blood pressure, ambulatory blood pressure monitoring, and echocardiographic abnormalities in women with polycystic ovary syndrome: role of obesity and androgen excess","volume":"63","author":"Luque-Ramirez","year":"2014","journal-title":"Hypertension"},{"key":"2023110708004567100_dmad015-B56","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.maturitas.2004.09.005","article-title":"Polycystic ovary syndrome in post-menopausal women\u2013marker of the metabolic syndrome","volume":"50","author":"Margolin","year":"2005","journal-title":"Maturitas"},{"key":"2023110708004567100_dmad015-B57","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1530\/EJE-14-0468","article-title":"Hyperandrogenism after menopause","volume":"172","author":"Markopoulos","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"2023110708004567100_dmad015-B58","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1210\/jc.2010-0130","article-title":"Hyperandrogenism in women with polycystic ovary syndrome persists after menopause","volume":"96","author":"Markopoulos","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2023110708004567100_dmad015-B59","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1530\/EJE-12-0550","article-title":"Study of carbohydrate metabolism indices and adipocytokine profile and their relationship with androgens in polycystic ovary syndrome after menopause","volume":"168","author":"Markopoulos","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"2023110708004567100_dmad015-B60","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"2023110708004567100_dmad015-B61","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness","year":"2021","journal-title":"Res Synth Methods"},{"key":"2023110708004567100_dmad015-B62","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0378-5122(92)90003-M","article-title":"The normal menopause transition","volume":"14","author":"McKinlay","year":"1992","journal-title":"Maturitas"},{"key":"2023110708004567100_dmad015-B63","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1089\/jwh.2015.5441","article-title":"Cardiovascular disease and 10-year mortality in postmenopausal women with clinical features of polycystic ovary syndrome","volume":"25","author":"Merz","year":"2016","journal-title":"J Womens Health (Larchmt)"},{"key":"2023110708004567100_dmad015-B64","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1210\/jc.2017-02421","article-title":"High androgens in postmenopausal women and the risk for atherosclerosis and cardiovascular disease: the Rotterdam Study","volume":"103","author":"Meun","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2023110708004567100_dmad015-B65","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/cen.14117","article-title":"The cardiovascular risk profile of middle-aged women with polycystic ovary syndrome","volume":"92","author":"Meun","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2023110708004567100_dmad015-B66","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/13697137.2017.1392501","article-title":"Prediction of age at menopause in women with polycystic ovary syndrome","volume":"21","author":"Minooee","year":"2018","journal-title":"Climacteric"},{"key":"2023110708004567100_dmad015-B67","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.maturitas.2017.11.005","article-title":"Variation in symptoms of depression and anxiety in midlife women by menopausal status","volume":"108","author":"Mulhall","year":"2018","journal-title":"Maturitas"},{"key":"2023110708004567100_dmad015-B68","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/humupd\/dmv063","article-title":"Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis","volume":"22","author":"Naderpoor","year":"2016","journal-title":"Hum Reprod Update"},{"key":"2023110708004567100_dmad015-B69","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1210\/jc.2018-00570","article-title":"Self-reported polycystic ovary syndrome is associated with hypertension: a Northern Finland Birth Cohort 1966 Study","volume":"104","author":"Ollila","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"2023110708004567100_dmad015-B70","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1210\/jc.2015-3543","article-title":"Weight gain and dyslipidemia in early adulthood associate with polycystic ovary syndrome: prospective cohort study","volume":"101","author":"Ollila","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2023110708004567100_dmad015-B71","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/humrep\/dew329","article-title":"Overweight and obese but not normal weight women with PCOS are at increased risk of Type 2 diabetes mellitus \u2013 a prospective, population-based cohort study","volume":"32","author":"Ollila","year":"2017","journal-title":"Hum Reprod"},{"key":"2023110708004567100_dmad015-B72","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.metabol.2019.01.015","article-title":"Diagnosis of disorders of glucose tolerance in women with polycystic ovary syndrome (PCOS) at a tertiary care center: fasting plasma glucose or oral glucose tolerance test?","volume":"93","author":"Ortiz-Flores","year":"2019","journal-title":"Metabolism"},{"key":"2023110708004567100_dmad015-B151","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2023110708004567100_dmad015-B73","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/(SICI)1097-0142(19971001)80:7<1360::AID-CNCR28>3.3.CO;2-X","article-title":"Association of Stein-Leventhal syndrome with the incidence of postmenopausal breast carcinoma in a large prospective study of women in Iowa","volume":"80","author":"Parazzini","year":"1997","journal-title":"Cancer"},{"key":"2023110708004567100_dmad015-B74","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3390\/biomedicines11010096","article-title":"Hyperandrogenic symptoms are a persistent suffering in midlife women with PCOS; a prospective cohort study in Sweden","volume":"11","author":"Persson","year":"2023","journal-title":"Biomedicines"},{"key":"2023110708004567100_dmad015-B75","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1210\/jc.2015-2123","article-title":"Androgen profile through life in women with polycystic ovary syndrome: a Nordic Multicenter Collaboration Study","volume":"100","author":"Pinola","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2023110708004567100_dmad015-B76","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1530\/EJE-22-0462","article-title":"Polycystic ovary syndrome and leukocyte telomere length: cross-sectional and longitudinal changes","volume":"187","author":"Polonen","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"2023110708004567100_dmad015-B77","doi-asserted-by":"crossref","first-page":"E868","DOI":"10.1210\/jc.2011-3357","article-title":"Relative contributions of oligomenorrhea and hyperandrogenemia to the risk of metabolic syndrome in midlife women","volume":"97","author":"Polotsky","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2023110708004567100_dmad015-B78","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1210\/jc.2013-4170","article-title":"Hyperandrogenic oligomenorrhea and metabolic risks across menopausal transition","volume":"99","author":"Polotsky","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2023110708004567100_dmad015-B79","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1210\/jc.2008-2583","article-title":"Adrenal androgen production capacity remains high up to menopause in women with polycystic ovary syndrome","volume":"94","author":"Puurunen","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2023110708004567100_dmad015-B80","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1210\/jc.2011-0039","article-title":"Unfavorable hormonal, metabolic, and inflammatory alterations persist after menopause in women with PCOS","volume":"96","author":"Puurunen","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2023110708004567100_dmad015-B81","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/09513590.2019.1650337","article-title":"Cardiovascular events among reproductive and menopausal age women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"36","author":"Ramezani Tehrani","year":"2020","journal-title":"Gynecol Endocrinol"},{"key":"2023110708004567100_dmad015-B82","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1210\/jc.2010-2959","article-title":"Reproductive hormone levels and anthropometry in postmenopausal women with polycystic ovary syndrome (PCOS): a 21-year follow-up study of women diagnosed with PCOS around 50 years ago and their age-matched controls","volume":"96","author":"Schmidt","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2023110708004567100_dmad015-B83","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2265.2012.04378.x","article-title":"Body composition, bone mineral density and fractures in late postmenopausal women with polycystic ovary syndrome \u2013 a long-term follow-up study","volume":"77","author":"Schmidt","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2023110708004567100_dmad015-B84","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/aogs.13054","article-title":"High androgen levels protect against hypothyroidism","volume":"96","author":"Schmidt","year":"2017","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2023110708004567100_dmad015-B85","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1210\/jc.2011-1677","article-title":"Cardiovascular disease and risk factors in PCOS women of postmenopausal age: a 21-year controlled follow-up study","volume":"96","author":"Schmidt","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2023110708004567100_dmad015-B86","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3109\/09513590.2014.895985","article-title":"Complement protein C3 and coronary artery calcium in middle-aged women with polycystic ovary syndrome and controls","volume":"30","author":"Snyder","year":"2014","journal-title":"Gynecol Endocrinol"},{"key":"2023110708004567100_dmad015-B87","volume-title":"Publication Bias in Meta-Analysis \u2013 Prevention, Assessment and Adjustments","author":"Sterne","year":"2005"},{"key":"2023110708004567100_dmad015-B88","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0895-4356(98)00010-9","article-title":"Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study","volume":"51","author":"Talbott","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"2023110708004567100_dmad015-B89","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1161\/01.ATV.20.11.2414","article-title":"Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women","volume":"20","author":"Talbott","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2023110708004567100_dmad015-B90","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2147\/VHRM.S1452","article-title":"Is there an independent effect of polycystic ovary syndrome (PCOS) and menopause on the prevalence of subclinical atherosclerosis in middle aged women?","volume":"4","author":"Talbott","year":"2008","journal-title":"Vasc Health Risk Manag"},{"key":"2023110708004567100_dmad015-B91","doi-asserted-by":"crossref","first-page":"6061","DOI":"10.1210\/jc.2003-032110","article-title":"The relationship between C-reactive protein and carotid intima-media wall thickness in middle-aged women with polycystic ovary syndrome","volume":"89","author":"Talbott","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2023110708004567100_dmad015-B92","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.1210\/jc.2003-032237","article-title":"Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome","volume":"89","author":"Talbott","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2023110708004567100_dmad015-B93","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"33","author":"Teede","year":"2018","journal-title":"Hum Reprod"},{"key":"2023110708004567100_dmad015-B94","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Hum Reprod"},{"key":"2023110708004567100_dmad015-B95","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"2023110708004567100_dmad015-B96","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/humupd\/dmaa029","article-title":"Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis","volume":"26","author":"Wekker","year":"2020","journal-title":"Hum Reprod Update"},{"key":"2023110708004567100_dmad015-B97","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1210\/jc.2013-2375","article-title":"Lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause","volume":"98","author":"Welt","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2023110708004567100_dmad015-B98","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.tem.2006.01.003","article-title":"Human ovarian theca cells in culture","volume":"17","author":"Wickenheisser","year":"2006","journal-title":"Trends Endocrinol Metab"},{"key":"2023110708004567100_dmad015-B99","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1210\/jc.2009-2724","article-title":"Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society","volume":"95","author":"Wild","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2023110708004567100_dmad015-B100","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.fertnstert.2010.12.027","article-title":"Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis","volume":"95","author":"Wild","year":"2011","journal-title":"Fertil Steril"},{"key":"2023110708004567100_dmad015-B101","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/1464727002000198781","article-title":"Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study","volume":"3","author":"Wild","year":"2000","journal-title":"Hum Fertil (Camb)"},{"key":"2023110708004567100_dmad015-B102","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0015-0282(99)00641-X","article-title":"Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome","volume":"73","author":"Winters","year":"2000","journal-title":"Fertil Steril"},{"key":"2023110708004567100_dmad015-B103","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1093\/humrep\/des232","article-title":"Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria","volume":"27","author":"Yildiz","year":"2012","journal-title":"Hum Reprod"},{"key":"2023110708004567100_dmad015-B104","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/GME.0000000000001055","article-title":"Association between polycystic ovary syndrome and hot flash presentation during the midlife period","volume":"25","author":"Yin","year":"2018","journal-title":"Menopause"},{"key":"2023110708004567100_dmad015-B105","volume-title":"Polycystic Ovary Syndrome","author":"Zawadzki","year":"1992"},{"key":"2023110708004567100_dmad015-B106","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.fertnstert.2018.09.013","article-title":"Metabolic disturbances in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"111","author":"Zhu","year":"2019","journal-title":"Fertil Steril"},{"key":"2023110708004567100_dmad015-B107","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/CEJ.0b013e328329d830","article-title":"Hormone-related factors and gynecological conditions in relation to endometrial cancer risk","volume":"18","author":"Zucchetto","year":"2009","journal-title":"Eur J Cancer Prev"}],"container-title":["Human Reproduction Update"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humupd\/article-pdf\/29\/6\/741\/52711866\/dmad015.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humupd\/article-pdf\/29\/6\/741\/52711866\/dmad015.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T03:03:04Z","timestamp":1699326184000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humupd\/article\/29\/6\/741\/7206372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,23]]},"references-count":108,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6,23]]},"published-print":{"date-parts":[[2023,11,2]]}},"URL":"https:\/\/doi.org\/10.1093\/humupd\/dmad015","relation":{},"ISSN":["1355-4786","1460-2369"],"issn-type":[{"value":"1355-4786","type":"print"},{"value":"1460-2369","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,12,1]]},"published":{"date-parts":[[2023,6,23]]}}}